Education
About Us
Working with TipRanks
Follow Us
Fluicell AB (DE:5J90)
:5J90
5J90 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.67 - €2.04
Previous CloseN/A
VolumeN/A
Average Volume (3M)291.00
Market Cap
€2.32M
Enterprise Value€7.73M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta20.92
Next Earnings
Nov 14, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding1,373,703
10 Day Avg. Volume0
30 Day Avg. Volume291
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
5J90 FAQ
What was Fluicell AB’s price range in the past 12 months?
Fluicell AB lowest stock price was €0.67 and its highest was €2.04 in the past 12 months.
What is Fluicell AB’s market cap?
Fluicell AB’s market cap is €2.32M.
When is Fluicell AB’s upcoming earnings report date?
Fluicell AB’s upcoming earnings report date is Nov 14, 2025 which is in 45 days.
How were Fluicell AB’s earnings last quarter?
Fluicell AB released its earnings results on Aug 15, 2025. The company reported -€0.19 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.19.
Is Fluicell AB overvalued?
According to Wall Street analysts Fluicell AB’s price is currently Overvalued.
Does Fluicell AB pay dividends?
Fluicell AB does not currently pay dividends.
What is Fluicell AB’s EPS estimate?
Fluicell AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fluicell AB have?
Fluicell AB has 1,373,703 shares outstanding.
What happened to Fluicell AB’s price movement after its last earnings report?
Fluicell AB reported an EPS of -€0.19 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.031%.
Which hedge fund is a major shareholder of Fluicell AB?
Currently, no hedge funds are holding shares in DE:5J90
Company Description
Fluicell AB
Fluicell AB (publ) provides single-cell discovery platforms for biomedicine, drug development, and bioprinting applications worldwide. The company offers BioPen PRIME and BioPen FLEX microfluidic systems for maintaining localized solution delivery in single-cell experiments, as well as enabling control of the chemical environment around single intact cells in tissue or cell cultures; and Dynaflow Resolve system, a secondary ion channel screening platform, which allows for recording of various ion channel current in patch-clamp recording configuration. The company was founded in 2012 and is based in Gothenburg, Sweden.
Technical Analysis
Diagonal Bio AB
―
LIDDS AB
―
NextCell Pharma AB
―
CombiGene AB
―
QuiaPEG Pharmaceuticals Holding AB
―